Emergency postcoital contraception

New England Journal of Medicine

Volumn 337, Issue 15, 1997, Pages 1058-1064

  Glasier, Anna ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL; ETHINYLESTRADIOL; LEVONORGESTREL; MIFEPRISTONE; POSTCOITUS CONTRACEPTIVE AGENT;

CONCEPTION; CONTRACEPTION; CORPUS LUTEUM FUNCTION; DRUG MEGADOSE; FEMALE; FERTILIZATION; HUMAN; IMPLANTATION; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUATION; NAUSEA; OVULATION; PREGNANCY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT PLANNING; VOMITING;

AMERICAS; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, POSTCOITAL; CONTRACEPTIVE EFFECTIVENESS; CONTRACEPTIVE MODE OF ACTION; DEVELOPED COUNTRIES; FAMILY PLANNING; FERTILITY CONTROL, POSTCOITAL; LITERATURE REVIEW; NORTH AMERICA; NORTHERN AMERICA; UNITED STATES;

CONTRACEPTION; CONTRACEPTIVES, POSTCOITAL; DANAZOL; EMBRYO IMPLANTATION; EMERGENCIES; ETHINYL ESTRADIOL; FEMALE; FERTILIZATION; HUMANS; INTRAUTERINE DEVICES; LEVONORGESTREL; OVULATION; PREGNANCY; PREGNANCY, UNWANTED;

EID: 0030884720     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199710093371507     Document Type: Review

References (50)

1. Van Look PFA, von Hertzen H. Induced abortion: a global perspective. In: Baird DT, Grimes DA, Van Look PFA, eds. Modern methods of inducing abortion. Oxford, England: Blackwell Science, 1995:1-24.
2. Trussell J, Stewart F. The effectiveness of postcoital contraception. Fam Plann Perspect 1992;24:262-4.
3. Trussell J, Ellertson C, Stewart F. The effectiveness of the Yuzpe regimen of emergency contraception. Fam Plann Perspect 1996;28:58-64.
4. Ho PC, Kwan MSW. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod 1993;8:389-92.
5. Van Santen MR, Haspels AA. A comparison of high-dose estrogens versus low-dose ethinylestradiol and norgestrel combination in postcoital interception: a study in 493 women. Fertil Steril 1985;43:206-13.
6. Haspels AA. Interception: post-coital estrogens in 3016 women. Contraception 1976;14:375-81.
7. Dixon GW, Schlesselmann JJ, Ory HW, Blye RP. Ethinyl estradiol and conjugated estrogens as postcoital contraceptives. JAMA 1980;244:1336-9.
8. Glasier A, Thong KJ, Dewar M, Mackie M, Baird DT. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med 1992;327:1041-4.
9. Webb AMC, Russell J, Elstein M. Comparison of the Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception. BMJ 1992;305:927-31.
10. Zuliani G, Colombo UF, Molla R. Hormonal postcoital contraception with an ethinylestradiol-norgestrel combination and two danazol regimens. Eur J Obstet Gynecol Reprod Biol 1990;37:253-60.
11. Trussell J, Ellertson C. Efficacy of emergency contraception. Fertil Control Rev 1995;4(2):8-11.
12. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation: effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med 1995;333:1517-21.
13. Ling WY, Wrixon W, Zayid I, Acorn T, Popat R, Wilson E. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium. Fertil Steril 1983;39:292-7.
14. Rowlands S, Kubba AA, Guillebaud J, Bounds W. A possible mechanism of action of danazol and an ethinylestradiol/norgestrel combination used as postcoital contraceptive agents. Contraception 1986;33:539-45.
15. Swahn M-L, Westlund P, Johannisson E, Bygdeman M. Effect of postcoital contraceptive methods on the endometrium and the menstrual cycle. Acta Obstet Gynecol Scand 1996;75:738-44.
16. Ledger WL, Sweeting VM, Hillier H, Baird DT. Inhibition of ovulation by low-dose mifepristone (RU 486). Hum Reprod 1992;7:945-50.
17. Alvarez F, Brache V, Fernandez E, et al. New insights on the mode of action of intrauterine contraceptive devices in women. Fertil Steril 1988; 49:768-73.
18. Chang MC, Harper MJK. Effects of ethinyl estradiol on egg transport and development in the rabbit. Endocrinology 1966;78:860-72.
19. Morris JM, Van Wagenen G. Interception: the use of postovulatory estrogens to prevent implantation. Am J Obstet Gynecol 1973;115:101-6.
20. Lehmann F, Just-Nastansky I, Behrendt B, Czygan P-J, Bettendorf G. Effect of post-ovulatory administered oestrogens on corpus luteum function. Acta Endocrinol (Copenh) 1975;79:329-36.
21. Swahn ML, Johannisson E, Daniore V, de la Torre B, Bygdeman M. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium. Hum Reprod 1988;3:915-21.
22. Swahn ML, Bygdeman M, Cekan S, Xing S, Masironi B, Johannisson E. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium. Hum Reprod 1990;5:402-8.
23. Gemzell-Danielsson K, Swahn M-L, Svalander P, Bygdeman M. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Hum Reprod 1993;8:870-3.
24. Hagenfeldt K. Studies on the mode of action of the copper-T device. Acta Endocrinol Suppl 1972;169:3-37.
25. Morris JM, Van Wagenen G. Compounds interfering with ovum implantation and development. 3. The role of estrogens. Am J Obstet Gynecol 1966;96:804-15.
26. Shirley B, Bundren JC, McKinney S. Levonorgestrel as a postcoital contraceptive. Contraception 1995;52:277-81.
27. Kubba AA, White JO, Guillebaud J, Elder MG. The biochemistry of human endometrium after two regimens of postcoital contraception: a dl-norgestrel/ethinylestradiol combination or danazol. Fertil Steril 1986;45: 512-6.
28. Couzinet B, Le Strat N, Silvestre L, Schaison G. Late luteal administration of the antiprogesterone RU486 in normal women: effects on the menstrual cycle events and fertility control in a long-term study. Fertil Steril 1990;54:1039-44.
29. Steiner M, Piedrahita C, Joanis C, Glover L, Spruyt A. Condom breakage and slippage rates among study participants in eight countries. Int Fam Plann Perspect 1994;20:55-8.
30. Yuzpe AA, Lancee WJ. Ethinylestradiol and dl-norgestrel as a postcoital contraceptive. Fertil Steril 1977;28:932-6.
31. Grou F, Rodrigues I. The morning-after pill - how long after? Am J Obstet Gynecol 1994;171:1529-34.
32. Thorogood M. Oral contraceptives and cardiovascular disease: an epidemiologic overview. Pharmacoepidemiol Drug Saf 1993;2:3-16.
33. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995;346:1575-82.
34. Jespersen J, Petersen KR, Skouby SO. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid. Am J Obstet Gynecol 1990;163:396-403.
35. Weenink GH, Ten Cate JW, Kahle LH, Lamping RJ, Treffers PE. "Morning after pill" and antithrombin III. Lancet 1981;1:1105.
36. Webb A, Taberner D. Clotting factors after emergency contraception. Adv Contracept 1993;9:75-82.
37. Improving access to quality care in family planning: medical eligibility criteria for contraceptive use. Geneva: World Health Organization, 1996: 31-3. (WHO/FRH/FPP/96.9.)
38. International Planned Parenthood Federation. IMAP statement on emergency contraception. IPPF Med Bull 1994;28(6):1-2.
39. Bracken MB. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstet Gynecol 1990;76:552-7.
40. Simpson JL, Phillips OP. Spermicides, hormonal contraception and congenital malformations. Adv Contracept 1990;6:141-67.
41. Glasier A, Ketting E, Ellertson C, Armstrong E. Emergency contraception in the United Kingdom and the Netherlands. Fam Plann Perspect 1996;28:49-51.
42. Fasoli M, Parazzini F, Cecchetti G, La Vecchia C. Post-coital contraception: an overview of published studies. Contraception 1989;39:459-68. [Erratum, Contraception 1989;39:699.]
43. Food and Drug Administration. Prescription drug products: certain combined oral contraceptives for use as emergency postcoital contraception. Fed Regist 1997;62(37):8610-2.
44. Ramsay S. What is the problem with emergency contraception? Lancet 1995;345:1169.
45. Glasier A. Availability, accessibility and use. In: Paintin D, ed. The provision of emergency hormonal contraception. London: RCOG Press, 1995:16-20.
46. Harper CC, Ellertson CE. The emergency contraceptive pill: a survey of knowledge and attitudes among students at Princeton University. Am J Obstet Gynecol 1995-173:1438-45.
47. Graham A, Green L, Glasier AF. Teenagers' knowledge of emergency contraception: questionnaire survey in south east Scotland. BMJ 1996; 312:1567-9.
48. Barnett AA. FDA advises on emergency contraception. Lancet 1996; 348:53
49. Glasier A. Emergency contraception: time for de-regulation? Br J Obstet Gynaecol 1993;100:611-2.
50. Williams C. New Zealand doctors resist emergency contraception. BMJ 1996;312:463.